Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 22.42 USD -0.8%
Market Cap: 1.5B USD

Wall Street
Price Targets

TNDM Price Targets Summary
Tandem Diabetes Care Inc

Wall Street analysts forecast TNDM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNDM is 22.39 USD with a low forecast of 14.14 USD and a high forecast of 57.75 USD.

Lowest
Price Target
14.14 USD
37% Downside
Average
Price Target
22.39 USD
0% Downside
Highest
Price Target
57.75 USD
158% Upside
Tandem Diabetes Care Inc Competitors:
Price Targets
603014
Shandong Weigao Blood Purification Products Co Ltd
12% Upside
OPTOMED
Optomed Oyj
34% Upside
300529
Jafron Biomedical Co Ltd
30% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
16% Upside
6849
Nihon Kohden Corp
31% Upside
228850
Rayence Co Ltd
41% Upside
6869
Sysmex Corp
55% Upside
TMDX
Transmedics Group Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Tandem Diabetes Care Inc

For the last 12 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 64%. The projected CAGR for the next 4 years is 9%.

64%
Past Growth
9%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNDM's stock price target?
Price Target
22.39 USD

According to Wall Street analysts, the average 1-year price target for TNDM is 22.39 USD with a low forecast of 14.14 USD and a high forecast of 57.75 USD.

What is Tandem Diabetes Care Inc's Revenue forecast?
Projected CAGR
9%

For the last 12 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 64%. The projected CAGR for the next 4 years is 9%.

Back to Top